Cannabis-Based Medicines for Chronic Neuropathic Pain in Adults
The 2025 Cochrane review on cannabis-based medicines neuropathic pain provides the most rigorous analysis of cannabinoid effectiveness for chronic nerve pain. This systematic review update incorporates recent trial data to inform evidence-based clinical…
The efficacy and safety of cannabinoids for mental and substance use disorders: a systematic review and meta-analysis
A landmark cannabinoids mental health disorders systematic review published in The Lancet Psychiatry examines cannabinoids for mental health and substance use disorders. This comprehensive analysis addresses critical evidence gaps. The findings directly…
Why Averages Fail Palliative Cannabis Patients – A New Framework
Randomized controlled trials often fail to capture what palliative care cannabis patients actually experience. A new contextual effectiveness framework argues that averaging subjective outcomes obscures genuine individual benefit. This Evidence Brief…
U.S. Department of Justice Issues Final Order Rescheduling Medical Cannabis
The final order rescheduling medical cannabis to Schedule III marks a pivotal federal policy shift. This change removes longstanding barriers to clinical research. It enables FDA-approved studies and standardized trials to advance cannabis medicine.
UCSD Study Highlights Risks of Youth Cannabis Use on Brain Development
Youth cannabis use neurodevelopment risks are a critical concern as adolescent brains develop until about age 25. The UCSD study adds important evidence on how cannabis may impact cognitive growth in teens. Understanding these risks helps clinicians…
Major International Cannabis Study Designed—But No Results Yet
The international cannabis study protocol aims to track medicinal and recreational users across multiple countries using ecological momentary assessment. This longitudinal research design addresses key gaps in cannabis effects on mood and cognition.…
Prenylated Apigenin Derivatives from Cannabis sativa L.: Isolation, Biosynthesis, and Anti …
Prenylated apigenin cannabis research reveals novel bioactive compounds from Cannabis sativa. These derivatives represent a unique class of flavonoids with potential therapeutic value. Understanding their biosynthesis may expand cannabis-based treatment…
An Investigation of Cannabis and Mood Study for Class Project ($25 RAFFLE FOR …)
Student-led cannabis research projects often lack proper clinical research standards, impacting data validity. This mood study highlights challenges in informal cannabis research. Clinicians should be aware of these issues when discussing cannabis…
Medical Cannabis Market Growth and Clinical Research Outlook 2026-2033
The medical cannabis market growth 2026 is driven by intensified clinical research and development of pharmaceutical-grade products. Clinicians must stay informed about emerging evidence to guide patient care. This evolving landscape promises more…
Proposed Rule Would Allow Expansion of Cannabis Research in Missouri
Missouri cannabis research expansion is proposed to enable new research facilities focused on cannabis clinical studies. This rule aims to remove restrictions limiting research infrastructure and accelerate evidence development. Clinicians could benefit…